{"id":"https://openalex.org/W2139806767","doi":"https://doi.org/10.1158/1535-7163.mct-10-0033","title":"Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520","display_name":"Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W2139806767","doi":"https://doi.org/10.1158/1535-7163.mct-10-0033","mag":"2139806767","pmid":"https://pubmed.ncbi.nlm.nih.gov/20571074"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-10-0033","doi":"https://doi.org/10.1158/1535-7163.mct-10-0033","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-10-0033","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139806767"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027017988","display_name":"Brian J. Tunquist","orcid":"https://orcid.org/0009-0001-9897-2806","observed_orcids":["https://orcid.org/0009-0001-9897-2806","https://orcid.org/0000-0002-4331-4515"]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian J. Tunquist","raw_affiliation_strings":["Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado","Translational Oncology, Array BioPharma, Inc., Boulder, Colorado 80301, USA. Brian.Tunquist@arraybiopharma.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210101899"]},{"raw_affiliation_string":"Translational Oncology, Array BioPharma, Inc., Boulder, Colorado 80301, USA. Brian.Tunquist@arraybiopharma.com","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013946717","display_name":"Richard D. Woessner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard D. Woessner","raw_affiliation_strings":["Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113873206","display_name":"Duncan H. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Duncan H. Walker","raw_affiliation_strings":["Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Translational Oncology and 2Pharmacology, Array BioPharma, Inc., Boulder, Colorado","institution_ids":["https://openalex.org/I4210101899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210101899"],"apc_list":null,"apc_paid":null,"fwci":1.5012,"has_fulltext":false,"cited_by_count":75,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.78444461,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"9","issue":"7","first_page":"2046","last_page":"2056"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.15199999511241913,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.875},{"id":"https://openalex.org/keywords/kinesin-spindle-protein-inhibitor","display_name":"kinesin spindle protein inhibitor","score":0.7599999904632568},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9210000038146973},{"id":"https://openalex.org/keywords/mitotic-cell-death","display_name":"mitotic cell death","score":0.8399999737739563},{"id":"https://openalex.org/keywords/mitotic-arrest","display_name":"mitotic arrest","score":0.8640000224113464},{"id":"https://openalex.org/keywords/mitotic-slippage","display_name":"mitotic slippage","score":0.9079999923706055},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7739999890327454},{"id":"https://openalex.org/keywords/spindle-assembly-checkpoint","display_name":"spindle assembly checkpoint","score":0.7179999947547913},{"id":"https://openalex.org/keywords/anti-apoptotic-proteins","display_name":"anti-apoptotic proteins","score":0.8479999899864197},{"id":"https://openalex.org/keywords/treatment-sensitivity","display_name":"treatment sensitivity","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C93304396","wikidata":"https://www.wikidata.org/wiki/Q14763008","display_name":"Mitosis","level":2,"score":0.8828092813491821},{"id":"https://openalex.org/C59006786","wikidata":"https://www.wikidata.org/wiki/Q15319390","display_name":"Kinesin","level":3,"score":0.6556084156036377},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5799373984336853},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5748320817947388},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5115035772323608},{"id":"https://openalex.org/C29452124","wikidata":"https://www.wikidata.org/wiki/Q835950","display_name":"Interphase","level":2,"score":0.5050507187843323},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.45465776324272156},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44789865612983704},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.44519150257110596},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4387661814689636},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.42594683170318604},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4244888722896576},{"id":"https://openalex.org/C20418707","wikidata":"https://www.wikidata.org/wiki/Q189933","display_name":"Microtubule","level":2,"score":0.41973134875297546},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.418149471282959},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3754340708255768},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12160441279411316},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09220445156097412},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008938","descriptor_name":"Mitosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016547","descriptor_name":"Kinesins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016547","descriptor_name":"Kinesins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053179","descriptor_name":"Caspase 7","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-10-0033","doi":"https://doi.org/10.1158/1535-7163.mct-10-0033","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-10-0033","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:20571074","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20571074","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309577","display_name":"Array BioPharma","ror":"https://ror.org/018axtd57"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1897096064","https://openalex.org/W1973363947","https://openalex.org/W1980923728","https://openalex.org/W1983782677","https://openalex.org/W1984295575","https://openalex.org/W1988678729","https://openalex.org/W1996180957","https://openalex.org/W2003278673","https://openalex.org/W2005452896","https://openalex.org/W2006999182","https://openalex.org/W2009486785","https://openalex.org/W2010228227","https://openalex.org/W2012835470","https://openalex.org/W2016110068","https://openalex.org/W2016548691","https://openalex.org/W2020246613","https://openalex.org/W2038745273","https://openalex.org/W2041230280","https://openalex.org/W2041417130","https://openalex.org/W2041724957","https://openalex.org/W2047521557","https://openalex.org/W2057942504","https://openalex.org/W2060821094","https://openalex.org/W2062133747","https://openalex.org/W2062963733","https://openalex.org/W2064937772","https://openalex.org/W2065540065","https://openalex.org/W2082169879","https://openalex.org/W2094912923","https://openalex.org/W2096059000","https://openalex.org/W2100382399","https://openalex.org/W2108489838","https://openalex.org/W2115268409","https://openalex.org/W2117443078","https://openalex.org/W2118691390","https://openalex.org/W2119543578","https://openalex.org/W2126552753","https://openalex.org/W2127429864","https://openalex.org/W2131536053","https://openalex.org/W2135491950","https://openalex.org/W2141836356","https://openalex.org/W2151395731","https://openalex.org/W2152876030","https://openalex.org/W2154603906","https://openalex.org/W2156764394","https://openalex.org/W2166467949","https://openalex.org/W2167950795","https://openalex.org/W2186151149","https://openalex.org/W2555250704","https://openalex.org/W2971366081","https://openalex.org/W3042036894","https://openalex.org/W7100962643"],"related_works":["https://openalex.org/W3085553006","https://openalex.org/W2980082465","https://openalex.org/W2504593737","https://openalex.org/W2143339380","https://openalex.org/W2582009649","https://openalex.org/W3152840643","https://openalex.org/W2554089838","https://openalex.org/W2085073923","https://openalex.org/W1509421652","https://openalex.org/W2944083662"],"abstract_inverted_index":{"Kinesin":[0],"spindle":[1,175],"protein":[2,125],"(KSP/Eg5)":[3],"inhibitors":[4],"are":[5,64,117,186],"novel":[6],"anticancer":[7],"agents":[8],"that":[9,199],"have":[10],"thus":[11],"far":[12],"shown":[13],"only":[14],"modest":[15],"activity":[16],"in":[17,66,82,106,118,140,154,161,192],"the":[18,37,51,123],"clinic.":[19],"Understanding":[20],"how":[21],"to":[22,30,35,55,86,97,156,163,189,194],"identify":[23,56],"patients":[24,200],"who":[25],"may":[26],"be":[27,210],"most":[28,115],"sensitive":[29],"treatment":[31,214],"is":[32,94,166],"clearly":[33],"needed":[34],"improve":[36],"development":[38],"of":[39,71,73,112,122,137,144,149],"these":[40],"molecules.":[41],"We":[42,197],"studied":[43],"four":[44],"multiple":[45],"myeloma":[46],"cell":[47,74,127,134,152],"lines":[48,75],"treated":[49],"with":[50,79,132,201,215],"KSP":[52,157,164,195,216],"inhibitor":[53],"ARRY-520":[54,98],"factors":[57],"important":[58],"for":[59,213],"initiating":[60],"apoptosis":[61,80,191],"while":[62,114],"cells":[63,116],"arrested":[65],"mitosis.":[67],"The":[68,89],"majority":[69],"(three":[70],"four)":[72],"underwent":[76],"mitotic":[77,101,133],"arrest,":[78],"occurring":[81],"mitosis":[83,185],"within":[84],"24":[85],"30":[87],"hours.":[88],"remaining":[90],"line":[91],"(NCI":[92],"H929)":[93],"temporally":[95],"refractory":[96],"treatment,":[99,113],"undergoing":[100],"slippage":[102],"and":[103,174],"subsequently":[104],"peaking":[105],"apoptotic":[107],"markers":[108],"after":[109],"72":[110],"hours":[111],"interphase.":[119],"Interestingly,":[120],"loss":[121],"antiapoptotic":[124],"myeloid":[126],"leukemia":[128],"1":[129],"(Mcl-1)":[130],"coincided":[131],"death.":[135],"Stabilization":[136],"Mcl-1":[138,150],"resulted":[139],"a":[141,169],"delayed":[142],"onset":[143],"apoptosis,":[145],"whereas":[146],"enforced":[147],"downregulation":[148],"increased":[151],"death":[153],"response":[155,193],"inhibition.":[158,196],"Thus,":[159],"variation":[160],"responses":[162],"inhibition":[165],"governed":[167],"by":[168],"balance":[170],"between":[171],"survival":[172,182],"proteins":[173,183],"checkpoint":[176],"integrity.":[177],"Cells":[178],"relying":[179],"on":[180,206],"short-lived":[181],"during":[184],"more":[187],"likely":[188],"undergo":[190],"propose":[198],"hematologic":[202],"malignancies,":[203],"which":[204],"rely":[205],"Mcl-1,":[207],"would":[208],"therefore":[209],"good":[211],"candidates":[212],"inhibitors.":[217]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139806767","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
